Health

University of Maryland study finds flu vaccine effectiveness varies widely

An analysis of 18 flu seasons found a 39.5% median effectiveness against medically attended flu, while researchers still recommend annual shots.

Tom Brennan

By Tom Brennan · Health & Medicine Correspondent

2 min read

University of Maryland study finds flu vaccine effectiveness varies widely
Photo: Medical Xpress

A University of Maryland flu vaccine effectiveness study found that protection against medically attended influenza varied considerably across 18 seasons, with a median effectiveness of 39.5%. The researchers said the result shows why the often-cited 40% to 60% range does not fully capture year-to-year uncertainty, but it does not change the recommendation for annual vaccination.

The analysis was published in JAMA Network Open and examined end-of-season vaccine-effectiveness estimates from the 2004-05 through 2023-24 influenza seasons, according to the University of Maryland School of Medicine.

What did the flu vaccine effectiveness study find?

The 39.5% figure is a median across the seasons studied, meaning results were higher in some years and lower in others. The analysis estimated that effectiveness in a single future season could fall within an approximate 16% to 59% prediction interval, the university said.

The study measured effectiveness against medically attended influenza. It did not measure protection against hospitalization or death, a distinction that limits how broadly the 39.5% estimate can be applied.

Researchers also reported antigenic mismatch in 11 of the 18 seasons. Antigenic mismatch means the strains included in a seasonal vaccine did not closely correspond with viruses circulating during that season; the university said such mismatches can reduce protection.

Why do researchers still recommend the annual flu shot?

University of Maryland researchers said their findings are about explaining variable results, rather than changing vaccination guidance. They described annual vaccination as the best available way to prevent influenza and reduce its complications while work continues on vaccines with more consistent protection.

That recommendation reflects the difference between a vaccine's measured effectiveness against one outcome and its broader public-health effects. The university cited Centers for Disease Control and Prevention estimates that vaccination during the 2023-24 season prevented 9.8 million flu-related illnesses, 120,000 hospitalizations and 7,900 deaths.

For people deciding which vaccines apply to them, an adult vaccine schedule guide can help frame the questions to review with a vaccination provider. The Maryland researchers said clearer communication about flu-shot performance could give patients, clinicians and public-health officials more realistic expectations without overlooking the benefits of vaccination.

This story draws on original reporting from Medical Xpress.